New COVID booster vaccines put to the test
NCT ID NCT05960097
Summary
This study tested new COVID-19 booster vaccines in healthy adults who were already vaccinated. Researchers compared the safety and immune response of these new vaccines against a standard control vaccine. They also tested how different storage conditions might affect one of the vaccines.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Sacramento, California, 95864, United States
-
GSK Investigational Site
Hollywood, Florida, 33024, United States
-
GSK Investigational Site
Peoria, Illinois, 61614-4896, United States
-
GSK Investigational Site
Bruce, Australian Capital Territory, 2617, Australia
-
GSK Investigational Site
Blacktown, New South Wales, 2148, Australia
-
GSK Investigational Site
Botany, New South Wales, 2019, Australia
-
GSK Investigational Site
Brookvale, New South Wales, 2100, Australia
-
GSK Investigational Site
Coffs Harbour, New South Wales, 2450, Australia
-
GSK Investigational Site
Darlinghurst, New South Wales, 2010, Australia
-
GSK Investigational Site
Kanwal, New South Wales, 2259, Australia
-
GSK Investigational Site
Maroubra, New South Wales, 2035, Australia
-
GSK Investigational Site
Merewether, New South Wales, 2291, Australia
-
GSK Investigational Site
Blacktown, Queensland, 4006, Australia
-
GSK Investigational Site
Sherwood, Queensland, 4068, Australia
-
GSK Investigational Site
Tarragindi, Queensland, 4075, Australia
-
GSK Investigational Site
Adelaide, South Australia, 5000, Australia
-
GSK Investigational Site
Camberwell, Victoria, 3124, Australia
Conditions
Explore the condition pages connected to this study.